Castle Biosciences: Tiffany Olson
Castle Biosciences has appointed Tiffany Olson to its board of directors. Olson has served as president of Nuclear & Precision Health Solutions at Cardinal Health since 2013, and served as president of NaviMed prior to that. She has also worked for Eli Lilly and Roche Diagnostics, where she attained the position of president and CEO of Roche Diagnostics Corporation. Olson currently serves as an ambassador with the American Cancer Society through the ResearcHERS: Women Fighting Cancer campaign, which helps fund cancer research led by women, and currently serves on the board of the Council on Radionuclides and Radiopharmaceuticals.